A Kansas woman has filed a dangerous drug lawsuit against Eli Lilly alleging that the company’s antidepressant drug Cymbalta caused her to develop the life-threatening skin condition Stevens-Johnson syndrome.
According to Lawyers USA Online (subscription required), Nanci Matos was prescribed Cymbalta in November 2009 to treat anxiety. Shortly after she began taking the drug, she developed a rash that worsened over time. In January 2010 she was diagnosed with Stevens-Johnson syndrome.
Matos claims in her dangerous drug lawsuit that Cymbalta was defectively designed, inadequately tested, and lacked proper warnings as to the dangers associated with its use, which caused her to develop her skin condition.
The dangerous drug lawsuit claimed that Eli Lilly ignored the Food and Drug Administration’s recommendations to include warnings for serious skin disorders on the Cymbalta labeling. The complaint states that Eli Lilly is legally answerable for its negligent and intentional failure to revise its product label to disclose known significant health risks, both in the Cymbalta label and Medication guide.
Matos charges against the drug maker include negligence, fraud, misrepresentation, and violating Kansas consumer protection law.